Modern Pathology

Journal

Publication Venue For

  • Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.  31:179-197. 2018
  • Prostate cancer: diagnostic criteria and role of immunohistochemistry..  31:S12-S21. 2018
  • Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study..  30:312. 2017
  • Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndrome.  30:146-156. 2017
  • High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.  29:511-515. 2016
  • Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: A comparative study.  28:1084-1100. 2015
  • The protective effect of p16 INK4a in oral cavity carcinomas: p16 Ink4A dampens tumor invasion-integrated analysis of expression and kinomics pathways.  28:631-653. 2015
  • Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.  28:612-630. 2015
  • Clinical heterogeneity of Xp11 translocation renal cell carcinoma: Impact of fusion subtype, age, and stage.  27:875-886. 2014
  • Sacrococcygeal teratomas: Clinico-pathological characteristics and isochromosome 12p status.  27:562-568. 2014
  • Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: Potential utility in diagnosis and management.  26:268-274. 2013
  • Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.  26:54-61. 2013
  • Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.  26:32-43. 2013
  • Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.  25:1543-1549. 2012
  • Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens.  25:140-144. 2012
  • Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.  24:1521-1529. 2011
  • Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.  24:1511-1520. 2011
  • Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.  24:1313-1319. 2011
  • Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: An immunohistochemical and nucleotide sequencing analysis.  24:1248-1253. 2011
  • ERG gene rearrangements are common in prostatic small cell carcinomas.  24:820-828. 2011
  • International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease.  24:26-38. 2011
  • ERG rearrangement is present in a subset of transition zone prostatic tumors.  23:1499-1506. 2010
  • TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.  22:1415-1422. 2009
  • TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.  22:1399-1400. 2009
  • A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.  22:1032-1043. 2009
  • Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.  22:1016-1022. 2009
  • TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.  22:359-365. 2009
  • Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor.  22:385-392. 2009
  • Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.  21:1337-1344. 2008
  • Profiling the expression pattern of GPI transamidase complex subunits in human cancer.  21:979-991. 2008
  • Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: Comparison with CK20 and correlation with coordinate expression of CK7.  19:1421-1428. 2006
  • Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.  19:392-398. 2006
  • Erythropoietin and erythropoietin receptor expression in human prostate cancer.  18:421-430. 2005
  • The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.  15:45-49. 2002
  • Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions.  14:1052-1058. 2001
  • Heterogeneity of androgen receptor content in advanced prostate cancer.  10:839-845. 1997
  • Integrated expression of glomerular extracellular matrix proteins and β1 integrins in monoclonal light chain-related renal diseases.  10:485-495. 1997
  • DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.  9:930-937. 1996
  • An analysis of prognostic features in infiltrating lobular carcinoma of the breast..  8:830-836. 1995
  • Evaluation of idiopathic esophageal ulceration for human immunodeficiency virus.  8:568-572. 1995
  • Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.  8:260-265. 1995
  • Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.  6:733-737. 1993
  • "Signet Ring" sinus histiocytosis mimicking metastatic adenocarcinoma: report of two cases with immunohistochemical and ultrastructural study..  5:497-500. 1992
  • Florid papillomatosis of the nipple: immunohistochemical and flow cytometric analysis of two cases..  3:288-293. 1990
  • Immunoreactivity in malignant mesotheliomas with antibodies to basement membrane components and their receptors..  3:11-18. 1990
  • International Standard Serial Number (issn)

  • 0893-3952
  • Electronic International Standard Serial Number (eissn)

  • 1530-0285